Nektar Therapeutics Logo Image

Nektar Therapeutics

Most Recent Annual Report

2019 Annual Report and Form 10K

Nektar Therapeutics

Nektar Therapeutics does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Archived Annual Reports

- 2018 Annual Report
- PDF
- 2017 Annual Report
- PDF
- 2016 Annual Report
- PDF
Show 13 more archives
- 2015 Annual Report
- PDF
- 2014 Annual Report
- PDF
- 2013 Annual Report
- PDF
- 2012 Annual Report
- PDF
2011 Annual Report
- 2011 Annual Report
- PDF
- 2010 Annual Report
- PDF
- 2009 Annual Report
- PDF
- 2008 Annual Report
- PDF
- 2007 Annual Report
- PDF
- 2006 Annual Report
- PDF
- 2005 Annual Report
- PDF
- 2004 Annual Report
- PDF
- 2003 Annual Report
- PDF

About Nektar Therapeutics

501-1000 Employees

Based in San Francisco, California

Visit website

Nektar Therapeutics, a clinical-stage biopharmaceutical company, engages in developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms. The company’s product pipeline consists of drug candidates across various therapeutic areas, including oncology, pain, anti-infectives, anti-viral, and immunology.

Ticker:: NKTR
Exchange:: NASDAQ (See More NASDAQ Companies)
Industry:: Drug Delivery (See More Drug Delivery Companies)
Sector:: Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?